Skip to main navigation Skip to search Skip to main content

European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease - The substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow

  • Olga Meulenbroek
  • , Sarah O'Dwyer
  • , Daan De Jong
  • , Gerrita Van Spijker
  • , Sean Kennelly
  • , Fiona Cregg
  • , Marcel Olde Rikkert
  • , Laila Abdullah
  • , Anders Wallin
  • , Cathal Walsh
  • , Robert Coen
  • , Rose Anne Kenny
  • , Leslie Daly
  • , Ricardo Segurado
  • , Anne Borjesson-Hanson
  • , Fiona Crawford
  • , Michael Mullan
  • , Ugo Lucca
  • , Rita Banzi
  • , Florence Pasquier
    • Laetitia Breuilh, Matthias Riepe, Janos Kalman, William Molloy, Magda Tsolaki, Robert Howard, Meulenbroek O. Jessica Adams, Siobhan Gaynor, Brian Lawlor
  • Radboud University Nijmegen
  • Trinity College Dublin, St James's Hospital
  • Trinity College Dublin
  • Roskamp Institute
  • University of Gothenburg
  • University College Dublin
  • Archer Pharmaceuticals Inc
  • IRCCS Istituto di ricerche farmacologiche Mario Negri - Milano, Bergamo, Ranica
  • Université de Lille
  • Ulm University
  • University of Szeged
  • University College Cork
  • Aristotle University of Thessaloniki
  • King's College London
  • Molecular Medicine Ireland (MMI)

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease - The substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Veterinary Science and Veterinary Medicine

Immunology and Microbiology